Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor agonists.

Thousands in KY go unscreened for colon cancer because they lack access or don't want colonoscopies or stool-based tests, but ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer. | Drug Discovery And ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

Exercising regularly in the three years after treatment for a common cancer could significantly improve survival rates, an international study has revealed. In the research, a total of 889 colon ...

Dear Doctors: I want to know more about how exercising gives you a better chance of recovering from colon cancer. I’ve been trying to help my brother-in-law, who just got diagnosed. He doesn’t ...

A three-year exercise program improved survival in colon cancer patients and kept disease at bay, a first-of-its-kind international experiment showed. With the benefits rivaling some drugs, experts ...

Researchers report that a three-year exercise program helped improve survival rates for people who have been treated for colon cancer. Experts say the findings could be helpful when doctors are ...

The results of a new study show aspirin therapy may reduce the likelihood of colon cancer killing patients whose tumors have a specific gene mutation, according to a news release. The study was ...

Staging means finding out how far colon cancer has spread in your body. Physicians group colon cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being the ...